Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
  • Dudewitbow@lemmy.zipEnglish
    61·
    5 months ago

    Reading the article, kinda happy that different countries are working on different cancer fighting mrna options that currently are on different phases.

  • AlmightyDoorman@kbin.earth
    40·
    5 months ago

    Can’t read the whole article due to paywall. Here are 2 thoughts for the half that i did read.

    • colorectal cancer makes a lot of sense as a target. it still is one of the most cancers with the highest mortality. At the same time we saw an uptick in colorectal cancer rates in young people (reason unknown, maybe microplastics maybe something else.). Furthemore colorectal cancer seems to be a great target for immunsystem modulating therapy. There was a paper 3 years bake in I think the NEJM where they put 18/18 (exact N not sure) patients in remission with PD-1 modulation which also activates the immun system.

    • Astra Zeneca (I believe) is also working on a mRNA vaccine for cancer that is quite far along. They are targeting melanoma in remission and reduced reoccurence of melanoma or metastasis after 3 years by 50%. So it seems like mRNA cancer vaccines will be a strong pillar for future cancer treatements.

    Sadly we saw in the past that russia sometimes bolsters their numbers for medication efficency. I hope it is not the case this time but i hope that the phase 2/3 trials will be very transparent to quench any doubts.

    • Guidy@lemmy.worldEnglish
      8·
      5 months ago

      Eh if they come up with a reliable way to defeat it I’d say it’s worth it.